Oruka Therapeutics Inc [ORKA] stock prices are down -2.72% to $20.76 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The ORKA shares have lost -2.63% over the last week, with a monthly amount drifted -6.91%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Oruka Therapeutics Inc [NASDAQ: ORKA] stock has seen the most recent analyst activity on October 11, 2024, when Stifel initiated its Buy rating and assigned the stock a price target of $49. Previously, H.C. Wainwright started tracking the stock with Buy rating on October 07, 2024, and set its price target to $45. On September 17, 2024, Leerink Partners initiated with a Outperform rating and assigned a price target of $44 on the stock. TD Cowen started tracking the stock assigning a Buy rating. Jefferies initiated its recommendation with a Buy and recommended $40 as its price target on September 13, 2024. Ascendiant Capital Markets started tracking with a Buy rating for this stock on February 27, 2018, and assigned it a price target of $2. In a note dated October 09, 2013, Dawson James initiated an Buy rating and provided a target price of $3.75 on this stock.
The stock price of Oruka Therapeutics Inc [ORKA] has been fluctuating between $10.07 and $33.00 over the past year. Currently, Wall Street analysts expect the stock to reach $40 within the next 12 months. Oruka Therapeutics Inc [NASDAQ: ORKA] shares were valued at $20.76 at the most recent close of the market. An investor can expect a potential return of 92.68% based on the average ORKA price forecast.
Analyzing the ORKA fundamentals
Gross Profit Margin for this corporation currently stands at None% with Operating Profit Margin at None%, Pretax Profit Margin comes in at None%, and Net Profit Margin reading is None%. To continue investigating profitability, this company’s Return on Assets is posted at None, Equity is None and Total Capital is None. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio ofNone.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 19.84 points at the first support level, and at 18.92 for the second support level. However, for the 1st resistance point, the stock is sitting at 21.67, and for the 2nd resistance point, it is at 22.59.
Ratios To Look Out For
It’s worth pointing out that Oruka Therapeutics Inc [NASDAQ:ORKA]’s Current Ratio is 22.89. Further, the Quick Ratio stands at 22.89, while the Cash Ratio is None.
Transactions by insiders
Recent insider trading involved JANUS HENDERSON GROUP PLC, 10% Owner, that happened on Aug 16 ’24 when 5818.0 shares were purchased. 10% Owner, JANUS HENDERSON GROUP PLC completed a deal on Jul 24 ’24 to buy 0.19 million shares. Meanwhile, 10% Owner JANUS HENDERSON GROUP PLC bought 30227.0 shares on Jul 25 ’24.
